Figure 1. Lornoxicam treatment decreases the severity of recurrent herpetic stromal keratitis. Latently infected mice were consecutively
treated with 0.4 mg/kg of lornoxicam (LOR) or an equal volume of saline on one day before UVB exposure and repeated on the
following six days post-UVB exposure. The mean score of corneal opacity in LOR-treated mice (HSK+LOR) was significantly lower
than that in the saline control mice (HSK), reaching significance on days 7 to day 21 (p=0.09). The asterisk indicates that
p<0.001 when compared to the HSK group at the corresponding time points.